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Abstract 
BACKGROUND: Glomus tumors are rare neoplasms accounting for less than 2% of all soft tissue tumors but 
multiple lesions may be seen in up to 10% of the patients. Solitary glomus tumor (GT) most frequently appears as 
small nodule in specific locations such as subungual region or deep dermis. However, rarely these entities have 
been observed in extracutaneous locations such as the gastrointestinal, cardiovascular, respiratory tracts, and 
other visceral organs. A small fraction of the GTs may present as tumors of uncertain malignant potential or as 
malignant glomus tumors. 
CASE PRESENTATION: We report a patient with multiple glomus tumors on the time of diagnosis, which was 
histologically diagnosed as an atypical glomus tumor following resection of a tumor thrombus in the left renal vein, 
inferior vena cava trombus with intracardial extension, and mitral valve specimen. The intramuscular lesion from 
the thigh was diagnosed as a glomus tumor of uncertain malignant potential. Further examinations revealed 
multiple lesions trough her body: kidneys, breast, heart and subcutaneous tissue. The diagnosis of glomus tumor 
of uncertain malignant potential versus glomus tumor with low malignant potential could be quite challenging, and 
the clinical course may be as a determining factor for final diagnosis.  
CONCLUSION: To our knowledge, this is the only known case of glomus tumor with multiple organ involvement 
and aggressive biological behavior at presentation. 
 
 
 
 
 
 
Introduction 
 
Glomus tumors (GTs) comprise less than 1,5-
2% of soft tissue tumors, and less than 10% of them 
consist of multiple GTs (MGTs) [1[, [2], [3]. Solitary GT 
most frequently appear as small nodules in specific 
locations such as the subungual regions of digits or 
the deep dermis of the palm, wrist, forearm, and foot. 
Rarely, these entities have been observed in 
extracutaneous locations, where the normal glomus 
body may be sparse or even absent, such as the 
gastrointestinal, cardiovascular, respiratory tracts, and 
other visceral organs [3].  
Malignant Glomus Tumors (MGTs) may 
present as familial or sporadic. Familial MGTs show 
autosomal dominant inheritance pattern, rarely 
associated with MEN II, A-V malformations or 
brachydactyly. In some cases, rearrangements of the 
glomulin gene (1p21-22) have been found [1]. 
A small fraction of the GTs may present as 
tumors of Uncertain Malignant Potential. Tumor size, 
mitotic activity and location, have been shown to be 
the major parameters correlating with the biological 
behavior of these tumors [4]. In such cases the clinical 
course of the disease cannot be readily anticipated, 
thus making the therapeutic approach difficult [2], [3], 
[4], [5], [6], [7], [8]. To our knowledge, this is the only 
known case of glomus tumor with multiple organ 
involvement and aggressive biological behavior at 
presentation. 
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Case Report 
 
A 38-year-old woman contacted her physician 
after she noticed two weeks previously, a mass at the 
anterior aspect of the left thigh. On CT, the lesion was 
slightly hypodense and located within vastus lateralis 
muscle, without intralesional calcifications or signs for 
hemorrhage (Figure 1A). After contrast administration 
there was a mild inhomogeneous peripheral 
enhancement in the early arterial phase, followed by 
subtle homogenous enhancement of the entire lesion 
in the delayed phase (Figure 1B). Magnetic resonance 
imaging showed a well-circumscribed lobulated mass 
with the largest diameter of 6 cm (craniocaudal), 
isointense to muscle on T1-weighted image (WI), 
inhomogeneous high signal on T2WI and with 
presence of mild peritumoral edema. After Gadolinium 
(Gd) contrast administration, there was 
inhomogeneous enhancement of the lesion (Figure 
1C, 1D, and 1E). Histopathological examination of the 
core biopsy specimen showed a small round cell 
tumor, in keeping with a sarcoma due to diffuse 
immunoreactivity with Vimentin, excluding Lymphoma, 
epithelial malignant neoplasm, but not excluding 
Ewing’s sarcoma due to focal imunoreactivity with 
CD99 antibody. A suggestion for further cytogenetic 
examination was given (Figure 1F). 
 
Figure 1: CT scan and Magnetic Resonance Imaging of the left 
thigh and corresponding histopathology of the core biopsy; A) pre 
contrast; B) after intravenous iodine contrast administration, early 
arterial phase; C) T1WI, axial plane; D) T2WI coronal plane; e) 
T1WI, axial plane, after intravenous gadolinium based contrast 
administration; F) Core biopsy specimen. The lesion is slightly 
hypodense compared to the normal muscle and is located within 
the left vastus lateralis muscle belly (arrows) A). On CT after 
contrast administration B) there is mild inhomogeneous peripheral 
enhancement of the lesion on early arterial phase (arrows), followed 
by subtle homogenous enhancement of the entire lesion in the 
delayed phase. On MR, within the left vastus lateralis muscle, there 
is a well-circumscribed lobulated mass, iso-intense to muscle on 
T1WI (arrow) C), and of heterogeneous signal on T2WI (arrow) D). 
The maximum craniocaudal diameter of the lesion is 6 cm . Note 
also mild peritumoral edema above upper and below lower pole of 
the lesion (arrows) D). After intravenous Gd administration, there 
was marked inhomogeneous enhancement of the lesion E). Core 
biopsy specimen shows highly cellular neoplastic tissue composed 
of relatively uniform, small to medium sized cells in diffuse-solid 
arrangement and foci of vaguely lobular architecture (HE x100) F) 
 
Abdominal CT showed bilateral lesions of the 
kidneys, a 6 cm large lesion in the lower pole of the 
right kidney and 12 cm large lesion in the lower pole 
of the left kidney. Both lesions were isodense on the 
precontrast image, with enhancement of the central 
part of the lesions at the arterial phase followed by 
mild inhomogeneous enhancement in the delayed 
phase (Figure 2). 
 
Figure 2: CT scan of bilateral kidney lesions, coronal reformatted A) 
and axial B) images. On abdominal CT scan after intravenous 
contrast administration there are large lesions within both kidneys, 
which are less enhancing than the surrounding cortex (arrows). On 
the distal pole of the right kidney 6 cm large lesion is present 
(craniocaudal diameter). The deformation of the contour of the left 
kidney (arrows) A) and distal pole enlargement of the left kidney 
due to 12 cm large lesion causing compression of the pyelocaliceal 
system. Both lesions are inhomogeneously isodense on the native 
scan, and show enhancement of the central parts at the arterial 
phase followed by mild inhomogeneous enhancement of the entire 
lesion in the delayed phase B). A thrombotic mass was present 
within the left renal vein extending within the inferior caval vein (not 
shown) 
 
A thrombotic mass within the left renal vein 
and inferior caval vein extended within the right 
atrium. On chest CT scans after intravenous contrast 
administration lobulated isodense masses were seen 
in the left ventricle and anterior aspect of the mitral 
valve with thickened left wall of the left ventricle which 
enhanced inhomogeneously on venous phase (Figure 
3).  
 
Figure 3: Cardiac glomus tumor presented on CT scan. On chest 
CT scans after intravenous contrast administration a lobulated 
isodense masses are seen in the left ventricle and anterior aspect 
of the mitral valve with thickened left wall of the left ventricle 
(arrows) A); On venous phase there is inhomogeneous mild 
enhancement of the lesion of the left ventricle wall (arrow) B) 
 
An additional lesion was found in the left 
breast (Figure 4) and two lesions within the 
subcutaneous fat of anterior abdominal wall (diameter 
1 cm each). 
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Figure 4: Imaging of glomus tumor on the left breast; A) 
Mammography; B) CT scan late venous phase. At mammography, 
craniocaudal view there is a retro-areolar dense lobulated lesion 
(arrow) A). On the chest CT scan after intravenous contrast material 
administration the lesion is highly vascular with homogenous 
enhancement on late venous phase B) presented as well-
delineated lobulated lesion measuring 1,5 cm in diameter (arrow) 
 
Further examination of the patient and 
therapy was done in another institution, where a core 
biopsy of the left kidney lesion suggested Ewing’s 
sarcoma. 
Urgent cardiac surgery was done, due to 
deterioration of cardiac symptoms (hypotension, 
dyspnea, shortness of breath, paroxysmal atrial 
fibrillation, decrease of ejection fraction under 30%) 
before any other therapeutic treatment. Preoperative 
cardiac ultrasound, which was six weeks after initial 
cardiac CT examination (Figure 3), showed a fibrillary 
mass within the left ventricle, with a diameter of 3.5 
cm, located near the thickened anterior mitral valve. 
During systole the mass extends to the aortic valve. A 
mobile hyperechoic mass with similar ultrasound 
characteristic is seen in the right atrium, with a 
maximum length of 5 cm, extending within the right 
ventricle during diastole. Cardiac surgery was 
performed, with thrombectomy and mitral valve 
replacement and placement of inferior vena cava filter, 
in suprarenal position. 
Shortly after the cardiac operation, the patient 
started with the first line chemotherapy according to 
VAC protocol (vincristine 1.5 mg/m
2
, doxorubicin 75 
mg/m
2
, and cyclophosphamide 1200 mg/m
2
 on day 1 
[9]. Two cycles of chemotherapy has been 
administered until the histopathological diagnosis was 
revised as atypical glomus tumor, following 
histopathological examination of the cardiac resection 
specimen and vena cava thrombotic/tumoral masses. 
The Ewing’s chemotherapy regime was discontinued 
and further chemotherapy with temozolomide 150 
mg/m
2
 (day 1-5) has been recommended. 
Three months later the follow-up images of 
the thigh lesion showed enlargement of the lesion and 
occurrence of small intramuscular lesions with similar 
MR appearance located in the same and in opposite 
leg (Figure 5). The main thigh lesion and nearby 
satellite nodule was removed with free surgical 
margins. 
 
Figure 5: Follow-up MR images on the thigh, after three months; A) 
Axial T1WI after intravenous contrast (Gd) administration; B) 
Coronal FS T1WI after intravenous contrast (Gd) administration. 
There is slight enlargement of the primary lesion and occurrence of 
new small intramuscular lesions in the same and in contralateral leg 
(arrows) 
 
Only postoperative positron emission 
computed tomography (PET-CT) scan was done, and 
previously described lesions on kidneys and breast, 
which were present before and after operation of the 
thigh lesion, shows no metabolic activities. 
 
Histopathologic and molecular features 
First diagnostic procedure was done in 
Macedonia. The initial core biopsy of the large soft 
tissue lesion located within m. vastus lateralis, 
revealed highly cellular neoplastic tissue composed of 
relatively uniform, small to medium sized cells in 
diffuse arrangement and foci of vaguely lobular 
architecture. The immuno-phenotype was quite non-
specific rendering a diagnosis of small cell sarcoma. 
Second diagnostic procedure was done in 
Turkey. Core biopsy of the left kidney mass, was 
histologically interpreted as a malignant tumor in favor 
of Ewing’s sarcoma. Although CD99 negative, 
approximately 40% of the tumor cells were positive for 
EWS RNA binding protein 1 (EWSR1) (22q12) 
rearrangement on Fluorescent in situ hybridization 
(FISH). Unfortunately, the results from other institution 
did not mention the translocation partner locus for the 
EWSR1 rearrangement. 
Third diagnostic procedure was done in 
Turkey. The “trombotic” masses surgically removed 
from both heart ventricles and vena cava inferior, and 
mitral valve specimen showed similar histological 
features to the kidney biopsy specimen, it expressed 
Smooth Muscle Actin (SMA) and laminin, besides 
vimentin. The Ki-67 proliferative index was around 
1%. Based on all previous clinical and histopathologic 
data, diagnosis of Atypical multiple glomus tumors 
was made for the first time in this case. 
Fourth diagnostic procedure was done in 
Macedonia. The surgical specimen consisted of skin 
fragment measuring 7 x 0.5 x 0.1 cm, with 
subcutaneous fat (8 x 3.5 x 0.7 cm) underlying 
skeletal muscle fragment (10 x 10 x 4 cm) and 
fragment of fascia (8 x 2 x 0.1 cm). On serial sections, 
a white-yellowish poorly demarcated tumor nodule (7 
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x 5.5 x 4 cm) was found in the muscle. The central 
part of the tumor consisted of dilated blood vessels 
filled with partially clotted blood. Another nodular 
lesion with the same macroscopic appearance was 
found subcutaneously. On light microscopy the tumor 
had a predominantly lobular architecture, composed 
of small-to medium-sized cells with moderate amount 
of eosinophilic or pale cytoplasm and relatively 
uniform nuclei with inconspicuous nucleoli (Figure 6), 
dispersed in scant collagen IV positive stroma with 
increased vascularity and foci of hemorrhage (Figure 
7D). The cells had perivascular arrangement in many 
areas. Only one regular mitotic figure per 50 HPF 
(high power fields) was detected. Marked nuclear 
atypia and atypical mitotic figures were not found. 
 
Figure 6: Histology of surgical specimen of the resected thigh mass. 
A lobular architecture of the tumor (HE x 40) (A); small irregular 
lumina are present within rich cellular lobules. SMA positivity (x 100) 
(arrows) (B) 
 
The positive immunohistochemical findings 
were to the antibodies to smooth muscle activity 
(SMA), Vimentin, Caldesmon and Collagen IV, shown 
in Table 1. The Ki-67 was expressed in less than 5% 
of tumor cells, and only one mitotic figure per 50 hpf 
was detected (Figure 7A, 7B, 7C, 7D, 7E, and 7F). 
Tumor cells were negative for immunostaining against 
Desmin, S-100 protein, EMA, HMB45, CD31 and 
CD34. The diagnosis of glomus tumor of uncertain 
malignant potential was made due to histological 
features, tumor size and subfascial localization. 
 
Figure 7: Microphotographs of various immunostaining (A); h-
Caldesmon positive cells surrounding blood vessel (B); The same 
antibody labeling glomus cells in areas of solid growth; some of 
them lining small lumina (upper part of the microphoto) (C) CD34 
 
Molecular analysis was performed using Next 
Generation Sequencing for 58 genes, Oncompass 
NGS hot spot panel, which did not identify any driver 
mutations. Polymorphisms and silent mutations were 
detected in five genes (PDGFRA, RET, JAK1, 
PIK3R1, CHEK2), as well as KDR gene mutation 
(Q472H) in about 49% of the cells which was not 
considered a driver mutation. The tumor was FISH 
negative for HER2, FGFR1 and EGFR 
amplification/rearrangement. On these grounds, 
diagnosis of glomus tumor of uncertain malignant 
potential was proposed. 
Follow up: The disease was stable 18 months 
after surgery of the thigh lesion and the start of 
Temozolomide (brand name Temodal) therapy, with 
absence of tumor progression. 
 
 
Discussion 
 
Glomus tumor is an uncommon mesenchymal 
neoplasm composed of modified smooth muscle cells, 
which are neoplastic counterparts of a perivascular 
glomus body. It is usually a small neoplasm that not 
exceeding 1 cm in diameter and located most 
commonly in the subungual region of the fingers in the 
distal extremities. It may also occur at the skin, 
subcutaneous fat and rarely in visceral organs [3], [4], 
[5], [6], [7], [8], [10], [11], [12], [13], [14], [15], [16]. 
GTs are more commonly seen in young adults 
[17] with rare onset after age 30 years. 
A glomus tumor is typically painful triggered 
by cold, without improvement after analgetics [10], 
[15], [18], [19], [20]. The lesion is sensitive to pressure 
and touch [18], [19], [20]. The reported mean duration 
of symptoms is 7.2 to 14.6 years [15], [17]. Glomus 
tumors are solitary lesions in 82%-90% [15], [21]. 
Another studies reported as multifocal lesions in up to 
25% of cases [17], [22]. Radiographic features of 
glomus tumors are usually not characteristic. On MRI, 
glomus tumors are of low signal intensity on T1-
weighted images, high signal intensity on T2-weighted 
images, and enhance vividly on postcontrast images 
[15], [16], [18], [20], [23], [24], [25]. In cases of 
multiple glomus tumors each superficial nodule has a 
similar MRI presentation to a solitary glomus tumor 
[26]. A more lobulated shape of the lesion with a more 
heterogeneous enhancement pattern of the masses 
makes differentiation from malignant vascular or 
sarcomatous tumors difficult [15]. 
Multiple glomus tumor usually present with 
atypical clinical features, pathology and location [27]. 
There is usually no family history [26], which is the 
main reason for delay in diagnosis. 
In our case, glomus tumors were histologically 
confirmed in the muscular compartment, kidney and 
heart. Imaging techniques showed similar to identical 
lesions in breast, most likely the same entity. 
Visceral localization of glomus tumor is rare 
[8], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], 
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[38], [39], [40], [41], [42]. To the best of our 
knowledge- synchronous location in multiple organs, 
as in our case, has not been reported. 
Glomus tumor should be considered 
malignant when the tumor is larger than 2 cm, has 
deep subfascial or visceral location and has histologic 
features of malignancy, such as atypical mitotic 
figures or marked nuclear atypia and any level of 
mitotic activity [4]. 
Malignant glomus tumor may metastasize to 
the bone, brain, liver, lung, small intestine, or adjacent 
lymph nodes [4]. 
Glomus tumors not fulfilling the criteria of 
malignancy but have at least one atypical feature 
other than nuclear pleomorphism are labeled “Glomus 
tumor of uncertain malignant potential” [43], [44], [45]. 
In our case the thigh lesion was larger than 2 cm, and 
had subfascial localization but it had no histologic 
features of malignancy. 
Malignant glomus tumors are very rare. Less 
than 10% of GTs are cases of MGTs. Most of the 
MGTs are sporadic cases, but occasionally may 
appear as familial cases with usually autosomal 
dominant inheritance pattern, may be rarely 
associated with MEN II syndrome, A-V malformations 
or brachydactyly [1], [4]. In some cases 
rearrangements of the glomulin gene (1p21-22) have 
been documented. Malignant glomus tumor present 
aggressive clinical behavior and specific 
immunohistochemical features. These tumors must be 
distinguished from several other types of 
malignancies, primarily EWS/PNET, 
hemangiopericytoma, epithelioid leiomyosarcoma and 
rhabdomyosarcoma. In most cases the differential 
diagnosis is relatively straightforward, based on 
morphology and specific immunophenotype, although 
in minority of cases it may be challenging. Unlike 
EWS/PNET, GTs are CD99 negative. 
Solitary fibrous tumor shows a mixture of 
spindle and epithelioid cells with indistinct cell 
borders, usually staghorn tumor vessels, generally 
more hazard architecture, and show less frequently 
SMA expression. Epitheloid leiomyosarcoma shows 
more diffuse architecture and are less vascular, 
frequently contain areas of tumor cell necrosis, and 
more prominent mitotic activity. Rhabdomyosarcoma 
and variants with similar architecture and cellular 
composition to GTs, could be readily distinguished by 
desmin expression. 
Our patient presented with multiple lesions at 
the time of diagnosis. The two consecutive surgeries, 
of the heart and of the thigh, revealed histology 
consistent with atypical glomus tumor and glomus 
tumor of uncertain malignant potential respectively. 
Histological criteria for malignant glomus tumor were 
not present. 
Synchronous occurrence of glomus tumor in 
kidneys, heart and thigh, histologically confirmed and 
the presence of similar lesions in other tissues and 
organs strongly suggest malignancy. Indeed the 
lesion in the left kidney was the largest one and was 
out of proportion in size to practically all other lesions. 
Both elements strongly suggest primary lesion in the 
kidney. The thigh lesion showed a satellite nodule 
near the first detected at second examination of the 
lesion, which indicates disease progression. Taking 
into consideration the above mentioned facts, the 
multiplicity, the disease progression and the criteria 
for malignancy of GTs [4], our case is considered as a 
malignant GT. This is also favored by the presence of 
multiple newly formed lesions, which would be 
interpreted as metastases in this context, and not 
multiple GTs. Another fact supporting this thesis is the 
presence of a lesion at the left heart ventricle wall. 
On the other hand, the “benign” microscopic 
appearance contradicts the malignant nature of the 
tumor. The main diagnostic problem at initial 
diagnosis of such cases would be the absence of data 
about the clinical and biological behavior of the 
disease. In this regard, glomus tumor of uncertain 
malignant potential would be a more appropriate 
diagnosis, which would probably justify a wait and 
watch follow-up policy. Beside the serial sections 
made of the tissue samples taken from the thigh 
lesion there is always a possibility of not enough 
sampling in such cases when a divergence between 
the histology and clinical course appear. 
Clinical condition controlled with 
Temozolomide stayed stabile for 18 months; that also 
support the idea that the lesions we were dealing was 
most likely a neoplasm with low malignat potential. 
That is why in our case, based upon clinical, 
histopathologic and molecular features of the tumor, 
diagnosis of glomus tumor of uncertain malignant 
potential versus glomus tumor with low-grade 
malignancy was outweighed. The rationale for 
favoring the diagnosis of GT with low malignant 
potential was the progressive clinical course, 
appearance of additional satellite nodules and the 
obvious need for chemotherapy, which finally resulted 
with the disease entering a steady state, with no 
remission, but neither further progression. 
The variable immunophenotype of the 
different tumor samples, combined with the 
inconsistent molecular features and failure to detect 
common driver mutation in obtained samples could 
indicate the presence of biologically distinct multiple 
GTs, one (or some) of which had developed malignant 
features. 
The management of glomus tumor remains 
controversial. Surgical resection is primary treatment 
option for tumors in suitable localization. 
Embolotherapy is not curative and the role of 
radiotherapy is controversial. Somatostatin was used 
in treatment of glomus tumor also, it provided slower 
growth, but was not curative [46], [47], [48], [49]. 
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Our patient started chemotherapy for Ewing’s 
sarcoma after kidney core biopsy showed 40% of the 
tumor cells positive for EWS RNA binding protein 1 
(EWSR1) (22q12) rearrangement on Fluorescent in 
situ hybridization (FISH). This therapy was stopped, 
after two cycles, when the diagnosis of atypical 
glomus tumor was made on the basis of histological 
analysis of the thrombotic mass specimens from vena 
cava and specimen from mitral valve. 
Due to progress of disease of our patient has 
started treatment with temozolomide as one of the 
chemotherapeutic options for salvage treatment of 
patients with unresectable or metastatic soft tissue 
sarcoma. Temozolomide is considered to be active 
agent in soft tissue sarcoma as monotherapy or in 
combination with other chemotherapeutic agents [49], 
[50]. 
Temozolomide as an oral agent and is 
performing as a prodrug of the alkylating agent 
dacarbazine. Therapeutic advantage of temozolomide 
is determined by its capability to alkylate/methylate 
DNA, which most often occurs at the N-7 or O-6 
positions of guanine residues. This methylation 
damages the DNA and triggers the death of tumor 
cells [51], [52].  
We conclude that diagnosis of glomus tumor 
of uncertain malignant potential versus GT with low 
malignant potential could be quite challenging, and 
the clinical course may be crucial for final diagnosis. 
Despite absence of histological criteria for 
malignant glomus tumor, setting of multiple glomus 
tumors, disease progression and aggressive biological 
behavior at presentation indicated low grade 
malignant glomus tumor. 
 
 
Compliance with Ethical Standards 
 
Informed consent was obtained from the 
patient included in the study 
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